Literature DB >> 9951850

Observations on the etiology and pathogenesis of intraductal papillary-mucinous neoplasms of the pancreas.

D S Longnecker1.   

Abstract

During the last two decades, intraductal papillary-mucinous neoplasms have been recognised as a group that should be distinguished from ductal adenocarcinomas. The literature for these tumors is confusing with the use of many different terms such as mucinous duct ectasia and, sometimes, there is a failure to distinguish them from mucinous cystic tumors. The recognition and apparently increasing incidence of these neoplasms is perhaps entirely attributable to improved diagnostic and imaging methods such as endoscopic retrograde pancreatography and computerized tomography. Experimental, molecular, and epidemiologic data suggest that the etiology of IPMN overlaps that of solid ductal adenocarcinomas.

Entities:  

Mesh:

Year:  1998        PMID: 9951850

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  11 in total

1.  Incidence, prevalence, and management of intraductal papillary mucinous neoplasm in Olmsted County, Minnesota, 1984-2005: a population study.

Authors:  Kaye M Reid-Lombardo; Jennifer St Sauver; Zhuo Li; William A Ahrens; K Krishnan Unni; Florencia G Que
Journal:  Pancreas       Date:  2008-08       Impact factor: 3.327

2.  Pseudomyxoma peritonei originating from urachus-case report and review of the literature.

Authors:  A K Agrawal; P Bobiński; Z Grzebieniak; J Rudnicki; G Marek; P Kobielak; M Kazanowski; S Agrawal; A Hałoń
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

3.  Prediction of invasive carcinoma in branch type intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Atsushi Kanno; Kennichi Satoh; Morihisa Hirota; Shin Hamada; Jun Umino; Hiromichi Itoh; Atsushi Masamune; Tohru Asakura; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2010-04-10       Impact factor: 7.527

4.  Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity.

Authors:  T A Sohn; C J Yeo; J L Cameron; C A Iacobuzio-Donahue; R H Hruban; K D Lillemoe
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

5.  Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate?

Authors:  Roberto Salvia; Stefano Crippa; Massimo Falconi; Claudio Bassi; Alessandro Guarise; Aldo Scarpa; Paolo Pederzoli
Journal:  Gut       Date:  2006-11-24       Impact factor: 23.059

6.  Multifocal intraductal papillary mucinous neoplasm of the pancreas--a case report.

Authors:  Kun-Chun Chiang; Jun Te Hsu; Huang-Yang Chen; Shyh Chuan Jwo; Tsann-Long Hwang; Yi Yin Jan; Chun-Nan Yeh
Journal:  World J Gastroenterol       Date:  2009-02-07       Impact factor: 5.742

7.  Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Authors:  Taylor A Sohn; Charles J Yeo; John L Cameron; Ralph H Hruban; Noriyoshi Fukushima; Kurtis A Campbell; Keith D Lillemoe
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

8.  Cystic tumors of the pancreas.

Authors:  Giovanni Morana; Alessandro Guarise
Journal:  Cancer Imaging       Date:  2006-07-13       Impact factor: 3.909

Review 9.  Intraductal Papillary Mucinous Neoplasm of Pancreas.

Authors:  Norman Oneil Machado; Hani Al Qadhi; Khalifa Al Wahibi
Journal:  N Am J Med Sci       Date:  2015-05

10.  Evaluation of serial changes of pancreatic branch duct intraductal papillary mucinous neoplasms by follow-up with magnetic resonance imaging.

Authors:  Alessandro Guarise; Niccolò Faccioli; Mauro Ferrari; Roberto Salvia; Roberto Pozzi Mucelli; Giovanni Morana; Alec J Megibow
Journal:  Cancer Imaging       Date:  2008-12-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.